vs
高露洁棕榄（CL）与林德（LIN）财务数据对比。点击上方公司名可切换其他公司
林德的季度营收约是高露洁棕榄的1.7倍（$8.8B vs $5.2B），林德净利率更高（17.5% vs -0.7%，领先18.1%），林德同比增速更快（5.8% vs 5.8%），林德自由现金流更多（$1.6B vs $1.3B），过去两年林德的营收复合增速更高（4.0% vs 1.6%）
高露洁棕榄是总部位于美国纽约市曼哈顿中城公园大道的跨国消费品企业，主营家居清洁、医疗护理、个人护理、宠物护理等品类产品的生产、分销及相关服务，旗下产品行销全球多地，在日用消费领域拥有广泛的市场认可度。
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
CL vs LIN — 直观对比
营收规模更大
LIN
是对方的1.7倍
$5.2B
营收增速更快
LIN
高出0.1%
5.8%
净利率更高
LIN
高出18.1%
-0.7%
自由现金流更多
LIN
多$296.0M
$1.3B
两年增速更快
LIN
近两年复合增速
1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.2B | $8.8B |
| 净利润 | $-36.0M | $1.5B |
| 毛利率 | 60.2% | — |
| 营业利润率 | 1.7% | 23.0% |
| 净利率 | -0.7% | 17.5% |
| 营收同比 | 5.8% | 5.8% |
| 净利润同比 | -104.9% | -11.3% |
| 每股收益（稀释后） | $-0.04 | $3.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLLIN
| Q4 25 | $5.2B | $8.8B | ||
| Q3 25 | $5.1B | $8.6B | ||
| Q2 25 | $5.1B | $8.5B | ||
| Q1 25 | $4.9B | $8.1B | ||
| Q4 24 | $4.9B | $8.3B | ||
| Q3 24 | $5.0B | $8.4B | ||
| Q2 24 | $5.1B | $8.3B | ||
| Q1 24 | $5.1B | $8.1B |
净利润CLLIN
| Q4 25 | $-36.0M | $1.5B | ||
| Q3 25 | $735.0M | $1.9B | ||
| Q2 25 | $743.0M | $1.8B | ||
| Q1 25 | $690.0M | $1.7B | ||
| Q4 24 | $738.0M | $1.7B | ||
| Q3 24 | $737.0M | $1.6B | ||
| Q2 24 | $731.0M | $1.7B | ||
| Q1 24 | $683.0M | $1.6B |
毛利率CLLIN
| Q4 25 | 60.2% | — | ||
| Q3 25 | 59.4% | — | ||
| Q2 25 | 60.1% | — | ||
| Q1 25 | 60.8% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 60.6% | — | ||
| Q1 24 | 60.0% | — |
营业利润率CLLIN
| Q4 25 | 1.7% | 23.0% | ||
| Q3 25 | 20.6% | 27.5% | ||
| Q2 25 | 21.1% | 27.7% | ||
| Q1 25 | 21.9% | 26.9% | ||
| Q4 24 | 21.5% | 27.4% | ||
| Q3 24 | 21.2% | 25.0% | ||
| Q2 24 | 21.6% | 26.4% | ||
| Q1 24 | 20.7% | 25.9% |
净利率CLLIN
| Q4 25 | -0.7% | 17.5% | ||
| Q3 25 | 14.3% | 22.4% | ||
| Q2 25 | 14.5% | 20.8% | ||
| Q1 25 | 14.1% | 20.6% | ||
| Q4 24 | 14.9% | 20.8% | ||
| Q3 24 | 14.6% | 18.5% | ||
| Q2 24 | 14.5% | 20.1% | ||
| Q1 24 | 13.5% | 20.1% |
每股收益（稀释后）CLLIN
| Q4 25 | $-0.04 | $3.28 | ||
| Q3 25 | $0.91 | $4.09 | ||
| Q2 25 | $0.91 | $3.73 | ||
| Q1 25 | $0.85 | $3.51 | ||
| Q4 24 | $0.89 | $3.61 | ||
| Q3 24 | $0.90 | $3.22 | ||
| Q2 24 | $0.89 | $3.44 | ||
| Q1 24 | $0.83 | $3.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $5.1B |
| 总债务越低越好 | $7.8B | $20.7B |
| 股东权益账面价值 | $54.0M | $38.2B |
| 总资产 | $16.3B | $86.8B |
| 负债/权益比越低杠杆越低 | 145.17× | 0.54× |
8季度趋势，按日历期对齐
现金及短期投资CLLIN
| Q4 25 | $1.4B | $5.1B | ||
| Q3 25 | $1.3B | $4.5B | ||
| Q2 25 | $1.2B | $4.8B | ||
| Q1 25 | $1.1B | $5.3B | ||
| Q4 24 | $1.3B | $4.8B | ||
| Q3 24 | $1.2B | $5.2B | ||
| Q2 24 | $1.1B | $4.6B | ||
| Q1 24 | $1.1B | $4.8B |
总债务CLLIN
| Q4 25 | $7.8B | $20.7B | ||
| Q3 25 | — | $18.6B | ||
| Q2 25 | — | $19.7B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | $7.0B | $15.3B | ||
| Q3 24 | — | $17.5B | ||
| Q2 24 | — | $16.9B | ||
| Q1 24 | — | $15.2B |
股东权益CLLIN
| Q4 25 | $54.0M | $38.2B | ||
| Q3 25 | $856.0M | $38.6B | ||
| Q2 25 | $702.0M | $38.5B | ||
| Q1 25 | $363.0M | $38.0B | ||
| Q4 24 | $212.0M | $38.1B | ||
| Q3 24 | $435.0M | $39.2B | ||
| Q2 24 | $123.0M | $38.2B | ||
| Q1 24 | $230.0M | $38.8B |
总资产CLLIN
| Q4 25 | $16.3B | $86.8B | ||
| Q3 25 | $17.5B | $86.0B | ||
| Q2 25 | $17.5B | $86.1B | ||
| Q1 25 | $16.6B | $82.7B | ||
| Q4 24 | $16.0B | $80.1B | ||
| Q3 24 | $16.8B | $82.5B | ||
| Q2 24 | $16.5B | $80.2B | ||
| Q1 24 | $16.6B | $80.3B |
负债/权益比CLLIN
| Q4 25 | 145.17× | 0.54× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | 33.04× | 0.40× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.5B | $3.0B |
| 自由现金流经营现金流 - 资本支出 | $1.3B | $1.6B |
| 自由现金流率自由现金流/营收 | 24.4% | 17.9% |
| 资本支出强度资本支出/营收 | 3.4% | 16.6% |
| 现金转化率经营现金流/净利润 | — | 1.98× |
| 过去12个月自由现金流最近4个季度 | $3.6B | $5.1B |
8季度趋势，按日历期对齐
经营现金流CLLIN
| Q4 25 | $1.5B | $3.0B | ||
| Q3 25 | $1.3B | $2.9B | ||
| Q2 25 | $884.0M | $2.2B | ||
| Q1 25 | $600.0M | $2.2B | ||
| Q4 24 | $1.3B | $2.8B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $990.0M | $1.9B | ||
| Q1 24 | $681.0M | $2.0B |
自由现金流CLLIN
| Q4 25 | $1.3B | $1.6B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | $776.0M | $954.0M | ||
| Q1 25 | $476.0M | $891.0M | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $1.0B | $1.7B | ||
| Q2 24 | $873.0M | $796.0M | ||
| Q1 24 | $555.0M | $906.0M |
自由现金流率CLLIN
| Q4 25 | 24.4% | 17.9% | ||
| Q3 25 | 21.6% | 19.4% | ||
| Q2 25 | 15.2% | 11.2% | ||
| Q1 25 | 9.7% | 11.0% | ||
| Q4 24 | 21.9% | 18.8% | ||
| Q3 24 | 20.5% | 19.9% | ||
| Q2 24 | 17.3% | 9.6% | ||
| Q1 24 | 11.0% | 11.2% |
资本支出强度CLLIN
| Q4 25 | 3.4% | 16.6% | ||
| Q3 25 | 3.0% | 14.8% | ||
| Q2 25 | 2.1% | 14.8% | ||
| Q1 25 | 2.5% | 15.7% | ||
| Q4 24 | 3.7% | 15.1% | ||
| Q3 24 | 2.7% | 12.8% | ||
| Q2 24 | 2.3% | 13.7% | ||
| Q1 24 | 2.5% | 12.9% |
现金转化率CLLIN
| Q4 25 | — | 1.98× | ||
| Q3 25 | 1.72× | 1.53× | ||
| Q2 25 | 1.19× | 1.25× | ||
| Q1 25 | 0.87× | 1.29× | ||
| Q4 24 | 1.72× | 1.63× | ||
| Q3 24 | 1.58× | 1.76× | ||
| Q2 24 | 1.35× | 1.16× | ||
| Q1 24 | 1.00× | 1.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CL
| Other | $3.0B | 58% |
| Pet Nutrition | $1.2B | 23% |
| Oral Personal And Home Care | $1.0B | 20% |
LIN
| Other | $4.9B | 56% |
| Packaged Gas | $1.6B | 19% |
| Merchant | $1.2B | 14% |
| On Site | $950.0M | 11% |
| Other Distribution Methods | $64.0M | 1% |
